Jun 1, 2026 11:00AM
May 6, 2026 04:05PM
Feb 25, 2026 04:05PM
Feb 19, 2026 08:00AM
Dec 16, 2025 06:53AM
Dec 12, 2025 04:56PM
Dec 12, 2025 04:56PM U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
Dec 11, 2025 06:35PM
Dec 11, 2025 06:35PM
Nov 5, 2025 04:05PM
Oct 20, 2025 08:01AM
Oct 20, 2025 08:00AM
Oct 7, 2025 08:00AM
Aug 13, 2025 08:00AM Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award
Aug 6, 2025 04:05PM
Jun 12, 2025 07:00AM
Jun 12, 2025 07:00AM
Jun 10, 2025 06:01AM
Jun 10, 2025 06:00AM
May 20, 2025 06:00AM
May 20, 2025 01:15AM Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
May 7, 2025 04:05PM
Mar 12, 2025 05:09PM
Mar 12, 2025 05:08PM
Feb 26, 2025 04:04PM
Dec 16, 2024 07:01AM
Dec 16, 2024 07:00AM
Nov 6, 2024 04:05PM Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
Jul 31, 2024 04:05PM
May 8, 2024 04:05PM
Feb 29, 2024 04:05PM
Oct 11, 2023 08:00AM
Sep 18, 2023 08:00AM
Aug 2, 2023 04:05PM
May 24, 2023 05:41AM Innoviva (INVA) Announces FDA Approval of XACDURO
May 23, 2023 06:42PM
May 12, 2023 05:41AM
May 11, 2023 06:45PM
May 9, 2023 04:32PM
Apr 17, 2023 04:32PM
Apr 17, 2023 04:31PM
Apr 17, 2023 09:01AM Innoviva (INVA) Confirms Stock Trading Halted Today Ahead of FDA Panel Meeting for Sulbactam-Durlobactam
Apr 17, 2023 09:00AM
Apr 17, 2023 08:57AM
Mar 14, 2023 05:22AM
Mar 13, 2023 06:24PM
Feb 28, 2023 04:10PM
Nov 30, 2022 04:30PM
Nov 30, 2022 04:30PM Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)
Oct 14, 2022 04:10PM

322,214 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All